心力衰竭的治療迷信指南還是相信自己-文庫吧
2024-12-22 03:54 本頁面
【正文】 ACC/AHA 2022 Guideline for the Diagnosis and Management of Chronic Heart Failure in the Adult 按照指南，對該病人的治療 適用 – 利尿劑 – ACEI or ARB – β－阻滯劑 – 洋地黃 – 安體舒通 – 口服硝酸鹽制劑＋肼苯噠嗪 不適用 – 鈣通道阻滯劑 非二氫吡啶類 二氫吡啶類（尚可，但短效增加死亡率） – 非甾體類抗炎藥 – 正性肌力藥物 問題： 一、按照剛才的方法，能夠解決病人的問題嗎？ 二、大家熟悉的強心（正性肌力藥物：多巴胺、多巴酚丁胺、氨力農、米力農等），利尿，擴血管治療（靜脈硝酸鹽制劑、硝普鈉等）是錯了的嗎？如果錯了，那為什么到現(xiàn)在有時使用還行之有效？ 仔細閱讀指南，可以看到 It specifically did not consider acute HF, which might merit a separate set of guidelines and is addressed in part in the ACC/AHA Guidelines for the Management of Patients With STElevation Myocardial Infarction and the ACC/AHA 2022 Update of the Guidelines for the Management of Unstable Angina and NonST Elevation Myocardial Infarction . — ACC/AHA 2022 Guideline for the Diagnosis and Management of Chronic Heart Failure in the Adult ESC Guidelines 2022 Guidelines on the diagnosis and treatment of acute heart failure Definition of AHF – Acute heart failure is defined as the rapid onset of symptoms and signs secondary to abnormal cardiac function. – It is often life threatening and requires urgent treatment. 針對急性心衰的治療 我們印象中的藥物 嗎啡 利尿 血管擴張劑（ 靜脈硝酸鹽制劑、硝普鈉等） ACEI or ARB 洋地黃 正性肌力藥物 指南對嗎啡的評價 ESC Guidelines 2022 Guidelines on the diagnosis and treatment of acute heart failure 指南對血管擴張劑的評價 指南對 ACEI的評價 ESC Guidelines 2022 Guidelines on the diagnosis and treatment of acute heart failure 指南對利尿劑的評價 ESC Guidelines 2022 Guidelines on the diagnosis and treatment of ac
教學課件相關推薦
鄂ICP備17016276號-1